Meg Tirrell is a biotechnology and pharma reporter for CNBC. ^{[1] [3] [7]} She is lives in New York, New York. ^{[2] [1] [3]}

Meg Tirrell attended Wellesley College from 2002 - 2006, receiving a Bachelor of Arts in English and Music. ^{[1] [3]} She then attended Northwestern University from 2006 - 2007, where she received a Master's degree in journalism. ^{[1] [3] [2]}

Prior to joining CNBC in March 2014, she covered the biotechnology business for Bloomberg News, where she likewise added to Bloomberg Businessweek.

[3] [1] [2]

She has covered improvement of new medications for Alzheimer's, malignancy and uncommon illnesses, and followed general wellbeing crises from Ebola to Zika.

Her work has investigated why less medications are created for youngsters, chronicled the sequencing of her own genome, and followed the assembling of an influenza shot from egg to drug store.

[1] [6] [5]

In 2014, she uncovered the horrifying dynamic behind Compassionate Use of unapproved drugs, and in 2016, she detailed broadly on drug estimating discussions and the effect of governmental issues on advancement of new meds.

[1] [2]